Development of therapeutic photodynamic corneal cross-linking: enzyme digestion studies

dc.contributor.advisorDr Sally Hayes and Dr Siân Morgan
dc.contributor.authorAMJAD NAIF ALMUTAIRI
dc.date2021
dc.date.accessioned2022-06-04T19:30:07Z
dc.date.available2022-01-25 02:38:12
dc.date.available2022-06-04T19:30:07Z
dc.description.abstractcorneal thickness and enzymatic resistance have shown successful results in keratoconus management with the assistance of riboflavin–UVA CXL, thereby reducing progression. Outcomes of pre-UVA rinse cross-linked treatment protocols handled with high intensity measures on corneal enzymatic resistance is yet to be further investigated. Both Ribo only and CXL with pre-UVA BSS rinse 10ml/20sec protocols resulted in negligible corneal enzymatic resistance. CXL with pre-UVA BSS rinse (1ml/2sec) and riboflavin replenishment protocol than the other treatment groups showed significant differences in enzymatic resistance towards digestion.
dc.format.extent91
dc.identifier.other109872
dc.identifier.urihttps://drepo.sdl.edu.sa/handle/20.500.14154/65923
dc.language.isoen
dc.publisherSaudi Digital Library
dc.titleDevelopment of therapeutic photodynamic corneal cross-linking: enzyme digestion studies
dc.typeThesis
sdl.degree.departmentSchool of Optometry and Vision Sciences
sdl.degree.grantorCardiff University
sdl.thesis.levelMaster
sdl.thesis.sourceSACM - United Kingdom

Files

Copyright owned by the Saudi Digital Library (SDL) © 2025